MetaADEDB 2.0 @ LMMD
Tiagabine
(YUKARLAABCGMCN-PKLMIRHRSA-N)
Structure
SMILES
OC(=O)[C@@H]1CCCN(C1)CCC=C(c1sccc1C)c1sccc1C.Cl
Molecular Formula:
C20H26ClNO2S2
Molecular Weight:
412.009
Log P:
5.7847
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
97.02
CAS Number(s):
145821-59-6
Synonym(s)
1.
Tiagabine
2.
(R)-(4,4-bis(3-Methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic acid, Hydrochloride
3.
Gabitril
4.
N-(4,4-di(3-Methylthien-2-yl)but-3-enyl)nipecotic acid
5.
NO 328
6.
NO 329
7.
NO-328
8.
NO-329
9.
Tiagabine Hydrochloride
10.
Tiagabine, (S)-isomer
External Link(s)
MeSHD000078308
PubChem Compound91274
74765398
ChEBI85388
CHEMBLCHEMBL1695
KEGGdr:D02097
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AgitationFAERS: 2US FAERS
2AstheniaFAERS: 2US FAERS
3Complex partial seizuresFAERS: 2US FAERS
4DeliriumFAERS: 2US FAERS
5DisorientationFAERS: 2US FAERS
6DizzinessFAERS: 2US FAERS
7Toxicity to various agentsFAERS: 2US FAERS
8TremorFAERS: 2US FAERS
9VomitingFAERS: 2US FAERS
10Accidental drug intake by childFAERS: 1US FAERS
11Accidental overdoseFAERS: 1US FAERS
12AmnesiaFAERS: 1US FAERS
13Blood glucose increasedFAERS: 1US FAERS
14Drug abuseFAERS: 1US FAERS
15Drug exposure during pregnancyFAERS: 1US FAERS
16Drug withdrawal syndromeFAERS: 1US FAERS
17DysarthriaFAERS: 1US FAERS
18Ectopic PregnancyFAERS: 1US FAERS
19Exposure during breast feedingFAERS: 1US FAERS
20Hallucinations, mixedFAERS: 1US FAERS
21Maternal exposure during pregnancyFAERS: 1US FAERS
22Memory impairmentFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.